Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.00
-0.35 (-1.91%)
At close: May 14, 2026

Daiken Biomedical Revenue

Daiken Biomedical had revenue of 463.84M TWD in the quarter ending March 31, 2026, with 38.55% growth. This brings the company's revenue in the last twelve months to 2.02B, up 39.00% year-over-year. In the year 2025, Daiken Biomedical had annual revenue of 1.90B with 39.10% growth.

Revenue (ttm)
2.02B
Revenue Growth
+39.00%
P/S Ratio
7.16
Revenue / Employee
n/a
Employees
20
Market Cap
14.50B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.90B532.70M39.10%
Dec 31, 20241.36B171.97M14.45%
Dec 31, 20231.19B305.45M34.52%
Dec 31, 2022884.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition